Recent Company News

• 11:57 PM ET Jun 26, 2025
  

  StreetAccount Summary - Trading higher/lower: Asia mid-morning

• 10:53 PM ET Jun 26, 2025
  

  StreetAccount Summary - Trading higher/lower: Hong Kong mid-morning

• 06:02 AM ET Jun 26, 2025
  

  BeOne Medicines publishes press release on highlights ahead of today's R&D Day ($267.13, 0.00)

• 05:05 PM ET Jun 23, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:50 AM ET Jun 25, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:02 AM ET Jun 25, 2025
  

  BeOne Medicines receives positive CHMP opinion for tablet formulation of BRUKINSA (zanubrutinib) for all approved indications ($266.80, 0.00)

• 03:23 PM ET Jun 22, 2025
  

  BeOne Medicines initiated buy at Southwest Securities (timing uncertain)

• 01:16 PM ET Jun 20, 2025
  

  StreetAccount Summary: Notable Drug Events expected for the week of 22-Jun